List of companies in Bain Capital Life Sciences's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes. | ||||||
Freenome is a San Francisco-based company which uses genetic analysis for early cancer detection and risk assessment. | ||||||
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that takes a precision medicine approach in acquiring, developing and commercializing medicines for patient populations that are suffering from rare diseases and cancer. | ||||||
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation. | ||||||
A company focused on mapping and controlling the genes to treat diseases | ||||||
Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company focused on solving Duchenne muscular dystrophy. | ||||||
A company offering a platform for home owners to buy and sell property. | ||||||
EQRx Inc is a biotechnology company. Its pipeline programs include two pre-registrational oncology assets that have shown assuring Phase 3 data (aumolertinib and sugemalimab), and multiple other clinical-stage programs. | ||||||
InflaRx is an antibodies for Inflammation founded in 2007 by Niels Riedemann, Renfeng Guo and Nicolas Fulpius. | ||||||
Replimune Group, Inc. is a clinical-stage biotechnology company. | ||||||
A biotechnology company the develops tools for detection of microbial contamination | ||||||
Xilio Therapeutics is a cancer Immunotherapies founded in 2016 by Rene Russo. | ||||||
Amylyx Pharmaceutical is a combination of existing products founded in 2013 by Justin Klee. | ||||||
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases. | ||||||
AAVANTIBio is a biotechnology company developing gene therapies. | ||||||
Pharvaris is a Zug-based company focused on the development of oral bradykinin-B2-receptor antagonists. | ||||||
Imperative Care is a Campbell, California-based medical technology company researching and developing products and devices for the treatment of vascular diseases such as stroke and pulmonary embolism. | ||||||
Rivus Pharmaceuticals is dedicated to improving cardio-metabolic health by developing controlled metabolic accelerators (CMAs) that address the underlying metabolic risk factors for cardiovascular mortality and morbidity. | ||||||
Gynesonics develops an ablatian device for uterine fibroids. | ||||||
Hugel is a Chuncheon-based company founded in 2001. | ||||||
At Serán, Our mission is to provide optimized drug development and manufacturing services for our clients, from discovery to the clinic. | ||||||
Kailera Therapeutics is a clinical-stage biotechnology company. |
